Zhejiang scientists unveil engineered immune cell therapy for heart failure
Heart failure affects more than 64 million people globally, and severe cases still carry a five-year mortality rate approaching 50% despite standard therapies.
Heart failure affects more than 64 million people globally, and severe cases still carry a five-year mortality rate approaching 50% despite standard therapies.